Releasing Factor

(redirected from releasing hormone)
Also found in: Dictionary, Thesaurus, Medical, Financial, Wikipedia.

Releasing Factor


(also releasing hormone), one of a group of neurohormones formed in the hypothalamus that act on the cells of the anterior lobe of the pituitary gland and stimulate or inhibit the secretion of tropic hormones into the blood. Extracts from the hypothalamus of humans and many vertebrate animals have been shown to contain specific releasing factors that stimulate the pituitary gland to release adrenocorticotropic hormone, luteinizing hormone, thyrotropin, folliclestimulating hormone, growth hormone, melanocyte-stimulating hormone, and prolactin. Releasing factors that inhibit the secretion of prolactin, melanocyte-stimulating hormone, and growth hormone have also been isolated.

All releasing factors appear to be peptides. For example, the releasing factor that stimulates the secretion of thyrotropin is a tripeptide—pyroglutamylhistidylpropylamide. This factor has been synthesized and is now used in medicine to detect local disorders of the hypothalamus, pituitary, and thyroid glands.


Iudaev, N. A., and Z. F. Evtikhina. “Sovremennye predstavleniia o gipotalamicheskikh rilizing-faktorakh.” In Sovremennye voprosy endokrinologii, fase. 4. Moscow, 1972.
“Hypophysiotropic Hormones of the Hypothalamus: Assay and Chemistry.” Proceedings of the Workshop Conference…. Baltimore, 1970.


References in periodicals archive ?
The gene for the neuropeptide gonadotropin releasing hormone is expressed in the mammary gland of lactating rats.
Ocular findings in adult subjects with an inactivating mutation in GH releasing hormone receptor gene.
A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor responders intervention trial (PRINT).
A family with hypogonadotropic hypogonadism and mutations in the gonadotropin releasing hormone receptor.
Corticotrophin releasing hormone: it's potential for role in human myometrium.
GH, LH, and PRL are major hormones of the anterior pituitary gland that are regulated by specific releasing hormones that bind to the corresponding releasing hormone receptor in the pituitary gland (Childs et al.
ObsEva reported follow-up results from the Phase 2b EDELWEISS clinical trial of its oral gonadotropin releasing hormone receptor antagonist, linzagolix, for the treatment of endometriosis-associated pelvic pain.
ELIGARD, which is a gonadotropin releasing hormone (GnRH) agonist indicated for the palliative treatment of advanced prostate cancer, is developed and manufactured by the company.
Tenders are invited for Supply of Gonadotrophin Releasing Hormone (GnRH)Analogue Solution for injection: 1 ml containing in 0.0042 mg buserelin acetate equivalent to0.004 mg buserelin.
The hormone, gonadotropin inhibitory hormone (GnIH), has the opposite effect from gonadotropin releasing hormone, a key reproductive hormone.
The chemosensory inputs that mediate RRLH in mice are detected by the vomeronasal organ, and relayed via the accessory olfactory bulb, and the vomeronasal amygdala, to the hypothalamic gonadotropin releasing hormone (GnRH) neurons.